Seagen
SGEN
#566
Rank
S$55.72 B
Marketcap
S$295.36
Share price
-0.07%
Change (1 day)
67.02%
Change (1 year)

Earnings for Seagen (SGEN)

Earnings in 2023 (TTM): -S$1.07 Billion

According to Seagen 's latest financial reports the company's current earnings are S$2.30 Billion. In 2022 the company made an earning of -S$0.8 Billion, an increase over its 2021 earnings that were of -S$0.89 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seagen from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$1.07 Billion34.72%
2022 -S$0.8 Billion-10.13%
2021 -S$0.89 Billion-214.28%
2020 S$0.77 B-370.63%
2019 -S$0.29 Billion-15.17%
2018 -S$0.34 Billion32.79%
2017 -S$0.26 Billion37.19%
2016 -S$0.19 Billion18%
2015 -S$0.16 Billion56.34%
2014 -S$99.9 Million23.07%
2013 -S$81.17 Million
2011 -S$0.19 Billion111.72%
2010 -S$88.06 Million-19.63%
2009 -S$0.11 Billion-7.55%
2008 -S$0.12 Billion64.95%
2007 -S$71.86 Million38.4%
2006 -S$51.92 Million25.36%
2005 -S$41.42 Million-14.86%
2004 -S$48.64 Million61.92%
2003 -S$30.04 Million-7.67%
2002 -S$32.54 Million6.76%
2001 -S$30.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$8.99 B-981.38%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$16.54 B-1,720.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$0.57 B-156.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$14.63 B-1,533.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$9.23 B-1,004.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-S$79.91 Million-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-S$81.07 Million-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.43 Billion-58.79%๐Ÿ‡บ๐Ÿ‡ธ USA